BÇü°£¿°¹ÙÀÌ·¯½ºÀÇ ¼öÁ÷°¨¿° ¿¹¹æ
Preventing Vertical Transmission of Hepatitis B virus
´ëÇѳ»°úÇÐȸÁö 2014³â 87±Ç 5È£ p.557 ~ p.564
ÃÖ¿øÇõ(Choe Won-Hyeok) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
ÀÌÁؼº(Lee June-Sung) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ÀÏ»ê¹éº´¿ø ³»°ú
Abstract
Vertical transmission of hepatitis B virus (HBV) is the main source of chronic infection in Korea, an HBV-endemic area, and chronically infected people are at high risk of developing liver cirrhosis or hepatocellular carcinoma. Thus, preventing vertical transmission is an important step in eradicating or reducing the burden of chronic HBV infection. However, despite passive-active immunoprophylaxis provided to infants, up to 10% of infants born to highly viremic mothers still become infected with HBV. Therefore, antiviral treatments or management protocols to reduce vertical transmission should be considered for highly viremic mothers and infants born to these mothers. Additionally, in-depth discussions with the mothers about the risks, benefits, and limitations of the current published data are essential. This article reviews the potential mechanisms of vertical transmission and current intervention strategies to prevent vertical transmission of HBV.
Å°¿öµå
Ç×¹ÙÀÌ·¯½ºÁ¦, BÇü°£¿°¹ÙÀÌ·¯½º, ¼öÁ÷°¨¿°, ÀÓ½Å
Antiviral agents, Hepatitis B virus, Vertical transmission, Pregnancy
KMID :
0882420140870050557
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)